SCHEMBL160981

SCHEMBL160981

[c]1ccnc(-c2ccccc2)c1-c1nc2cc(CN3CCOCC3)ccc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.43
ALDH1A1 P00352 2/20 0.43
HSD17B10 Q99714 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
GRIN2B Q13224 2/20 0.43
PARP1 P09874 3/20 0.42
KIT P10721 1/20 0.42
CDK1 P06493 3/20 0.41
AURKA O14965 2/20 0.41
CCNB1 P14635 2/20 0.41
CDK2 P24941 2/20 0.41
AURKB Q96GD4 2/20 0.41
ALOX5 P09917 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
GPR84 Q9NQS5 3/20 0.39
KDR P35968 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902772 0.71 PDPK1 (0.43) HPGDALDH1A1HSD17B10L3MBTL1PARP1
SCHEMBL26964466 0.71 KIT (0.42) HPGDALDH1A1HSD17B10L3MBTL1GRIN2B
SCHEMBL22235844 0.71 KIT (0.48) PARP1KITCDK1AURKACCNB1
SCHEMBL7444669 0.70 PARP1 (0.57) HPGDALDH1A1HSD17B10L3MBTL1GRIN2B
SCHEMBL16229465 0.70 AURKA (0.48) HPGDALDH1A1HSD17B10PARP1KIT
SCHEMBL5287220 0.70 FGFR1 (0.52) HPGDALDH1A1HSD17B10L3MBTL1PARP1
SCHEMBL546253 0.69 FGFR1 (0.45) HPGDALDH1A1HSD17B10L3MBTL1PARP1
SCHEMBL8262963 0.69 FGFR1 (0.51) HPGDALDH1A1HSD17B10L3MBTL1PARP1
SCHEMBL3539733 0.69 NCF1 (0.47) HPGDALDH1A1PARP1KDM4ENPC1
SCHEMBL110204 0.69 CDK1 (0.44) HPGDALDH1A1HSD17B10L3MBTL1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424843-A1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES Novartis AG (CH) 2012-03-07 EP disclosed
WO-2010125402-A1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES NOVARTIS AG (CH) 2010-11-04 WO disclosed